The Delta-Specific Opioid Glycopeptide BBI-11008: CNS Penetration and Behavioral Analysis in a Preclinical Model of Levodopa-Induced Dyskinesia

Lignende værker

• CNS penetration of the opioid glycopeptide MMP-2200: A microdialysis study
  af: Mabrouk, Omar S., et al.
  Udgivet: (2012)
• The combination of the opioid glycopeptide MMP-2200 and a NMDA receptor antagonist reduced L-DOPA-induced dyskinesia and MMP-2200 by itself reduced dopamine receptor 2-like agonist-induced dyskinesia
  af: Flores, Andrew J., et al.
  Udgivet: (2018)
• Behavioral pharmacology of the mixed-action delta-selective opioid receptor agonist BBI-11008: Studies on acute, inflammatory and neuropathic pain, respiration, and drug self-administration
  af: Stevenson, Glenn W., et al.
  Udgivet: (2020)
• Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model
  af: Bartlett, Mitchell J., et al.
  Udgivet: (2020)
• CNS active O-linked glycopeptides
  af: Jones, Evan M., et al.
  Udgivet: (2015)